A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies

Table 5 ELISA and IFAT results for malaria-risk blood donors

ELISA analytical specificity and sensitivity are respectively 96.8% (879/908) (CI: 95.6 – 98%) and 40% (6/15) (CI: 0.8 – 79.2%) in comparison to IFAT, equivocal results considered as positive for calculation.

ISSN: 1475-2875